Free Trial

Establishment Labs (ESTA) Competitors

Establishment Labs logo
$37.47 -0.34 (-0.90%)
Closing price 09/12/2025 04:00 PM Eastern
Extended Trading
$37.49 +0.02 (+0.07%)
As of 09/12/2025 05:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ESTA vs. TMDX, SLNO, NVST, LIVN, INSP, WRBY, LQDA, PRCT, LMAT, and AORT

Should you be buying Establishment Labs stock or one of its competitors? The main competitors of Establishment Labs include TransMedics Group (TMDX), Soleno Therapeutics (SLNO), Envista (NVST), LivaNova (LIVN), Inspire Medical Systems (INSP), Warby Parker (WRBY), Liquidia Technologies (LQDA), PROCEPT BioRobotics (PRCT), LeMaitre Vascular (LMAT), and Artivion (AORT). These companies are all part of the "medical equipment" industry.

Establishment Labs vs. Its Competitors

Establishment Labs (NASDAQ:ESTA) and TransMedics Group (NASDAQ:TMDX) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, valuation, media sentiment, analyst recommendations, profitability, dividends, institutional ownership and risk.

In the previous week, TransMedics Group had 4 more articles in the media than Establishment Labs. MarketBeat recorded 7 mentions for TransMedics Group and 3 mentions for Establishment Labs. Establishment Labs' average media sentiment score of 1.67 beat TransMedics Group's score of 1.02 indicating that Establishment Labs is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Establishment Labs
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
TransMedics Group
3 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Establishment Labs currently has a consensus price target of $56.50, suggesting a potential upside of 50.79%. TransMedics Group has a consensus price target of $122.11, suggesting a potential upside of 6.58%. Given Establishment Labs' stronger consensus rating and higher probable upside, equities analysts plainly believe Establishment Labs is more favorable than TransMedics Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Establishment Labs
0 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.83
TransMedics Group
0 Sell rating(s)
4 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.70

TransMedics Group has higher revenue and earnings than Establishment Labs. Establishment Labs is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Establishment Labs$177.42M6.12-$84.60M-$3.05-12.29
TransMedics Group$531.29M7.35$35.46M$1.9359.36

Establishment Labs has a beta of 0.85, suggesting that its stock price is 15% less volatile than the S&P 500. Comparatively, TransMedics Group has a beta of 2.18, suggesting that its stock price is 118% more volatile than the S&P 500.

72.9% of Establishment Labs shares are held by institutional investors. Comparatively, 99.7% of TransMedics Group shares are held by institutional investors. 11.1% of Establishment Labs shares are held by insiders. Comparatively, 7.0% of TransMedics Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

TransMedics Group has a net margin of 13.49% compared to Establishment Labs' net margin of -49.89%. TransMedics Group's return on equity of 28.02% beat Establishment Labs' return on equity.

Company Net Margins Return on Equity Return on Assets
Establishment Labs-49.89% -224.34% -25.53%
TransMedics Group 13.49%28.02%8.64%

Summary

TransMedics Group beats Establishment Labs on 12 of the 16 factors compared between the two stocks.

Get Establishment Labs News Delivered to You Automatically

Sign up to receive the latest news and ratings for ESTA and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ESTA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ESTA vs. The Competition

MetricEstablishment LabsMedical Services IndustryMedical SectorNASDAQ Exchange
Market Cap$1.10B$7.66B$5.87B$10.13B
Dividend YieldN/A2.77%5.68%4.60%
P/E Ratio-12.2974.0174.5225.93
Price / Sales6.1242.19517.44183.79
Price / CashN/A24.1437.5660.44
Price / Book19.727.3512.166.29
Net Income-$84.60M$238.91M$3.28B$270.77M
7 Day Performance-4.00%2.63%0.87%3.88%
1 Month Performance-2.27%1.47%4.96%4.88%
1 Year Performance-15.23%16.57%60.75%26.01%

Establishment Labs Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ESTA
Establishment Labs
2.3012 of 5 stars
$37.47
-0.9%
$56.50
+50.8%
-11.4%$1.10B$177.42M-12.291,018Positive News
TMDX
TransMedics Group
2.7088 of 5 stars
$114.96
-1.5%
$123.00
+7.0%
-23.2%$3.92B$441.54M59.57210
SLNO
Soleno Therapeutics
4.4396 of 5 stars
$67.67
-1.1%
$115.09
+70.1%
+8.1%$3.60BN/A-16.3530Trending News
Analyst Upgrade
Short Interest ↑
Analyst Revision
NVST
Envista
3.9295 of 5 stars
$21.15
-0.5%
$20.92
-1.0%
+12.7%$3.52B$2.51B66.0812,300Positive News
LIVN
LivaNova
2.9204 of 5 stars
$56.37
+1.7%
$59.71
+5.9%
+15.3%$3.08B$1.25B-14.492,900Positive News
INSP
Inspire Medical Systems
4.9034 of 5 stars
$93.86
+2.6%
$165.62
+76.4%
-60.6%$2.77B$802.80M54.261,246Positive News
WRBY
Warby Parker
1.6929 of 5 stars
$26.16
-0.3%
$24.06
-8.0%
+86.3%$2.76B$771.32M-373.723,780Positive News
Insider Trade
LQDA
Liquidia Technologies
3.5901 of 5 stars
$27.68
+0.8%
$32.11
+16.0%
+167.4%$2.38B$14M-16.2850Positive News
PRCT
PROCEPT BioRobotics
3.0311 of 5 stars
$40.17
-0.4%
$74.88
+86.4%
-53.8%$2.23B$224.50M-25.92430Positive News
LMAT
LeMaitre Vascular
3.2425 of 5 stars
$95.36
+0.1%
$97.60
+2.3%
+4.7%$2.16B$219.86M46.29490Positive News
AORT
Artivion
2.7279 of 5 stars
$43.87
+0.1%
$40.63
-7.4%
+64.4%$2.07B$388.54M-104.451,600Positive News

Related Companies and Tools


This page (NASDAQ:ESTA) was last updated on 9/13/2025 by MarketBeat.com Staff
From Our Partners